{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:11:25Z","timestamp":1793841085381,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jfma.2022.08.023","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T08:14:01Z","timestamp":1663316041000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-2431","authenticated-orcid":false,"given":"Tzu-Ching","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Chiao","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5154-0045","authenticated-orcid":false,"given":"Ih-Jane","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Jou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8648-0882","authenticated-orcid":false,"given":"Jehn-Hsiahn","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7592-3238","authenticated-orcid":false,"given":"Shee-Uan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jfma.2022.08.023_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-0528.1997.tb11525.x","article-title":"Assisted conception following poor ovarian response to gonadotrophin stimulation","volume":"104","author":"Keay","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.jfma.2022.08.023_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1472-6483(10)60946-7","article-title":"Management of poor responders in IVF","volume":"10","author":"Ubaldi","year":"2005","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"10.1016\/j.jfma.2022.08.023_bib3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/humrep\/den107","article-title":"Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial","volume":"23","author":"Lainas","year":"2008","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.jfma.2022.08.023_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tjog.2019.05.007","article-title":"The different impact of stimulation duration on oocyte maturation and pregnancy outcome in fresh cycles with GnRH antagonist protocol in poor responders and normal responders","volume":"58","author":"Yang","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jfma.2022.08.023_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fertnstert.2014.04.010","article-title":"Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in\u00a0vitro fertilization cycles","volume":"102","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.jfma.2022.08.023_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-018-0335-0","article-title":"An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders","volume":"16","author":"Huang","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.jfma.2022.08.023_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12958-019-0518-3","article-title":"Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study","volume":"17","author":"Peng","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.jfma.2022.08.023_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jfma.2022.08.023_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11596-019-2055-x","article-title":"Flexible GnRH antagonist protocol versus progestin-primed ovarian stimulation (PPOS) protocol in patients with polycystic ovary syndrome: comparison of clinical outcomes and ovarian response","volume":"39","author":"Xiao","year":"2019","journal-title":"Curr Med Sci"},{"issue":"2","key":"10.1016\/j.jfma.2022.08.023_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rbmo.2019.03.212","article-title":"Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?","volume":"39","author":"La Marca","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.jfma.2022.08.023_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02227-w","article-title":"Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jfma.2022.08.023_bib12","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jfma.2019.12.006","article-title":"A novel GnRH-antagonist protocol by switching to medroxyprogesterone when patients being at risk of ovarian hyperstimulation syndrome during ovarian stimulation","volume":"119","author":"Huang","year":"2020","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"10.1016\/j.jfma.2022.08.023_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12958-022-00996-1","article-title":"Usage and cost-effectiveness of elective oocyte freezing: a retrospective observational study","volume":"20","author":"Yang","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"10.1016\/j.jfma.2022.08.023_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jogoh.2018.10.008","article-title":"Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF\/ICSI compared to a GnRH antagonist protocol: a retrospective study","volume":"48","author":"Huang","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.jfma.2022.08.023_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. Gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial","volume":"10","author":"Chen","year":"2019","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.jfma.2022.08.023_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jfma.2017.05.009","article-title":"Feasibility of corifollitropin alfa\/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients","volume":"117","author":"Hwang","year":"2018","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"10.1016\/j.jfma.2022.08.023_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jfma.2018.05.011","article-title":"Advantages of cumulative pregnancy outcomes in freeze-all strategy in high responders - a case-control matching analysis of a large cohort","volume":"117","author":"Wu","year":"2018","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.jfma.2022.08.023_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(00)01701-5","article-title":"A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in\u00a0vitro fertilization outcome","volume":"75","author":"Gordon","year":"2001","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.jfma.2022.08.023_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/humupd\/dmu009","article-title":"The kisspeptin-GnRH pathway in human reproductive health and disease","volume":"20","author":"Skorupskaite","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"1 Pt 1","key":"10.1016\/j.jfma.2022.08.023_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jfma.2018.01.012","article-title":"Lower rate of early pregnancy loss in patients experiencing early-onset low LH in GnRH antagonist cycles supplemented with menotropin","volume":"118","author":"Yang","year":"2019","journal-title":"J Formos Med Assoc"},{"issue":"11","key":"10.1016\/j.jfma.2022.08.023_bib21","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1093\/oxfordjournals.humrep.a135807","article-title":"Gonadotrophin surge-inhibiting\/attenuating factor governs luteinizing hormone secretion during the ovarian cycle: physiology and pathology","volume":"10","author":"de Koning","year":"1995","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.jfma.2022.08.023_bib22","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/humrep\/16.7.1353","article-title":"Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women","volume":"16","author":"Fowler","year":"2001","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.jfma.2022.08.023_bib23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/humrep\/17.3.634","article-title":"Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles","volume":"17","author":"Martinez","year":"2002","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.jfma.2022.08.023_bib24","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(99)00414-8","article-title":"Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon\/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers","volume":"72","author":"Obery\u00e9","year":"1999","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.jfma.2022.08.023_bib25","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","volume":"15","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.jfma.2022.08.023_bib26","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/endo.140.2.6490","article-title":"Progesterone can block transmission of the estradiol-induced signal for luteinizing hormone surge generation during a specific period of time immediately after activation of the gonadotropin-releasing hormone surge-generating system","volume":"140","author":"Harris","year":"1999","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.jfma.2022.08.023_bib27","article-title":"A meta-analysis of the efficacy of progestin-primed ovarian stimulation with medroxyprogesterone acetate in ovulation induction in poor ovarian responders","volume":"50","author":"Cai","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.jfma.2022.08.023_bib28","article-title":"Co-administration of clomiphene citrate and Letrozole in mild ovarian stimulation versus conventional controlled ovarian stimulation among POSEIDON group 4 patients","volume":"12","author":"Lin","year":"2021","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.jfma.2022.08.023_bib29","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.fertnstert.2010.12.046","article-title":"In\u00a0vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle","volume":"95","author":"Kummer","year":"2011","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jfma.2022.08.023_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.fertnstert.2011.06.042","article-title":"Is a premature rise in luteinizing hormone in the absence of increased progesterone levels detrimental to pregnancy outcome in GnRH antagonist in\u00a0vitro fertilization cycles","volume":"96","author":"Dovey","year":"2011","journal-title":"Fertil Steril"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622003333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622003333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:48:34Z","timestamp":1760539714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664622003333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0929664622003333"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2022.08.023","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2022.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}